Harrow Health (NASDAQ:HROW) specializes in the development, production, and sale of innovative medications and services for the healthcare sector, focusing primarily on ophthalmology and oncology. The company takes pride in its ability to identify unmet medical needs and respond with effective solutions, driving forward projects that aim to bring significant improvements to patient care. Harrow Health's objectives are centered around expanding its product line, enhancing its research and development capabilities, and establishing strategic partnerships to reach broader markets. The company's dedication to innovation and patient care underpins its operations and future growth strategy, with a keen focus on delivering value to patients, healthcare professionals, and shareholders alike.